BR0016796A - Composições antimicrobianas e métodos de uso - Google Patents

Composições antimicrobianas e métodos de uso

Info

Publication number
BR0016796A
BR0016796A BR0016796-7A BR0016796A BR0016796A BR 0016796 A BR0016796 A BR 0016796A BR 0016796 A BR0016796 A BR 0016796A BR 0016796 A BR0016796 A BR 0016796A
Authority
BR
Brazil
Prior art keywords
methods
compositions
infectivity
relates
present
Prior art date
Application number
BR0016796-7A
Other languages
English (en)
Portuguese (pt)
Inventor
James R Baker Jr
Terek Hamouda
Amy Shih
Myc Andrzej
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of BR0016796A publication Critical patent/BR0016796A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Colloid Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR0016796-7A 1999-12-30 2000-12-29 Composições antimicrobianas e métodos de uso BR0016796A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47486699A 1999-12-30 1999-12-30
US09/561,111 US6506803B1 (en) 1999-04-28 2000-04-28 Methods of preventing and treating microbial infections
PCT/US2000/035651 WO2001049296A1 (en) 1999-12-30 2000-12-29 Antimicrobial compositions and methods of use

Publications (1)

Publication Number Publication Date
BR0016796A true BR0016796A (pt) 2003-06-10

Family

ID=27044598

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016796-7A BR0016796A (pt) 1999-12-30 2000-12-29 Composições antimicrobianas e métodos de uso

Country Status (11)

Country Link
US (1) US6506803B1 (https=)
EP (2) EP1242095B1 (https=)
JP (2) JP5013495B2 (https=)
CN (1) CN1433314B (https=)
AU (1) AU2609901A (https=)
BR (1) BR0016796A (https=)
CA (1) CA2395678C (https=)
DK (1) DK1242095T3 (https=)
ES (1) ES2425971T3 (https=)
MX (1) MXPA02006564A (https=)
WO (1) WO2001049296A1 (https=)

Families Citing this family (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655252B2 (en) * 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US8232320B2 (en) * 1999-04-28 2012-07-31 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
TR200200776T2 (tr) * 1999-09-24 2002-06-21 Smithkline Beecham Biologicals S.A. Burun içi grip virüsü aşısı.
US6794352B2 (en) 2000-06-12 2004-09-21 Jeffrey S. Svendsen Cleaning towel having a color identifying label and sanitizer release polymer composition
WO2004030608A2 (en) * 2001-06-05 2004-04-15 The Regents Of The University Of Michigan Nanoemulsion vaccines
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
BR0212163A (pt) * 2001-08-28 2004-12-07 Eden Reseaech Plc Composição para tratamento ou prevenção de infecção em plantas
US6667290B2 (en) 2001-09-19 2003-12-23 Jeffrey S. Svendsen Substrate treated with a binder comprising positive or neutral ions
US7745686B2 (en) 2001-11-02 2010-06-29 Playtex Products, Inc. Catamenial device
US7799968B2 (en) * 2001-12-21 2010-09-21 Kimberly-Clark Worldwide, Inc. Sponge-like pad comprising paper layers and method of manufacture
US20030175318A1 (en) * 2002-03-06 2003-09-18 Schilling Amanda S. Application of germination solution improved efficacy of biological decontamination
DE60215558T2 (de) * 2002-04-17 2007-08-02 Agribiotec S.R.L. Benutzung von pflanzlichem öl als adjuvantien für fungizide, bakterizide, insektizide oder herbizide substanzen
GB0213097D0 (en) 2002-06-07 2002-07-17 Autoglym Improvements in or relating to organic matter
US20040111817A1 (en) * 2002-12-17 2004-06-17 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
US7994079B2 (en) * 2002-12-17 2011-08-09 Kimberly-Clark Worldwide, Inc. Meltblown scrubbing product
WO2004077954A1 (en) 2003-03-05 2004-09-16 Byocoat Enterprises, Inc., Antimicrobial solution and process
WO2005002337A1 (en) * 2003-04-02 2005-01-13 Virtual Drug Development, Inc. Disinfectant compositions and methods
US20040204496A1 (en) * 2003-04-11 2004-10-14 Ammon Daniel M. Disinfecting solutions effective against bacterial endospores
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
AU2004273779B2 (en) * 2003-06-04 2009-10-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US7348097B2 (en) * 2003-06-17 2008-03-25 Medtronic, Inc. Insulative feed through assembly for electrochemical devices
PL1648412T3 (pl) * 2003-07-07 2008-04-30 Nares Ab Mikroemulsje i ich zastosowanie do zapobiegania chorobom dróg oddechowych
US8211448B2 (en) * 2003-07-07 2012-07-03 Nares Ab Microemulsions and its use for preventing airway diseases
US20090232748A1 (en) * 2003-11-07 2009-09-17 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
WO2005046738A2 (en) * 2003-11-07 2005-05-26 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20050130536A1 (en) * 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
US20050129897A1 (en) * 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
US20050136772A1 (en) * 2003-12-23 2005-06-23 Kimberly-Clark Worldwide, Inc. Composite structures containing tissue webs and other nonwovens
AU2005207622B2 (en) 2004-01-23 2010-10-28 Eden Research Plc Methods of killing nematodes comprising the application of a terpene component
US7707931B2 (en) * 2004-04-06 2010-05-04 West Liberty Foods, L.L.C. Clean room food processing systems, methods and structures
ES2461178T3 (es) * 2004-05-20 2014-05-19 Eden Research Plc Partícula hueca de glucano o de pared celular que encapsula un componente de terpeno
US20050260138A1 (en) * 2004-05-21 2005-11-24 Virgil Flanigan Producton and use of a gaseous vapor disinfectant
NZ534007A (en) 2004-07-09 2007-06-29 Horticulture & Food Res Inst Fungicidal composition comprising anhydrous milk fat (AMF) and soybean oil for the treatment of Powdery Mildew
US20060135026A1 (en) * 2004-12-22 2006-06-22 Kimberly-Clark Worldwide, Inc. Composite cleaning products having shape resilient layer
CA2600054A1 (en) * 2005-03-09 2006-09-21 Combe Incorporated Stable mixed emulsions
CA2604392A1 (en) * 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
US20060292248A1 (en) * 2005-06-20 2006-12-28 Bio-Germ Protection, Llc Biological attack protection kit and method
US20070015738A1 (en) * 2005-07-15 2007-01-18 Walker Stephen G Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells
JP2009504805A (ja) 2005-08-09 2009-02-05 ナノバイオ コーポレーション 抗炎症活性を有するナノエマルジョン組成物
CA2621459C (en) * 2005-09-03 2014-11-04 Byocoat Enterprises, Inc. Antimicrobial solutions and process related thereto
CA2600288A1 (en) * 2005-09-19 2007-04-12 Combe Incorporated Stable emulsion systems with high salt tolerance
PL2982244T3 (pl) 2005-11-30 2021-08-09 Eden Research Plc Kapsułki owadobójcze zawierające tymol oraz sposoby ich wytwarzania i zastosowania
KR101478012B1 (ko) 2005-11-30 2015-01-02 에덴 리서치 피엘씨 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
TWI458495B (zh) * 2006-03-23 2014-11-01 Glaxosmithkline Llc 牙齒器具清潔劑
US20080038295A1 (en) * 2006-04-13 2008-02-14 Regents Of The University Of Michigan Compositions and methods for orthopox virus vaccination
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US9839685B2 (en) * 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
WO2008103416A1 (en) * 2007-02-21 2008-08-28 Capps Charles L Synergistic enhancement of calcium propionate
CN101032507B (zh) * 2007-04-06 2010-09-29 西北农林科技大学 一种红霉素纳米乳抗菌药物及其制备方法
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
EP2280690A2 (en) * 2008-04-18 2011-02-09 Nanobio Corporation Methods for treating herpes virus infections
WO2009131995A1 (en) 2008-04-21 2009-10-29 Nanobio Corporation Nanoemulsion influenza vaccine
JP2011518844A (ja) * 2008-04-25 2011-06-30 ナノバイオ コーポレーション 真菌、酵母および糸状菌感染症を治療するためのナノエマルション
WO2009132343A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating onchomycosis
AU2009248810B2 (en) * 2008-05-23 2013-12-05 The Regents Of The University Of Michigan Nanoemulsion vaccines
EP2293814A4 (en) * 2008-05-23 2013-02-13 Univ Michigan NANOEMULSION AGENTS
FR2933104B1 (fr) * 2008-06-26 2015-10-09 Biomerieux Sa Milieu de culture comportant un compose inhibiteur ou retardateur de germination de spores
RU2371328C1 (ru) * 2008-07-01 2009-10-27 Государственное образовательное учреждение высшего профессионального образования Иркутский государственный университет Способ временной обратимой консервации артефактов
EP2349209A2 (en) 2008-09-26 2011-08-03 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
WO2010042212A2 (en) 2008-10-10 2010-04-15 Dara Biosciences, Inc. Methods for treating or preventing pain using spicamycin derivatives
US9974844B2 (en) 2008-11-17 2018-05-22 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
WO2010061330A1 (en) * 2008-11-26 2010-06-03 Viroblock S.A. Methods for inhibiting gram-positive bacteria using non-phospholipid lipid vesicules
US20100226983A1 (en) * 2009-01-28 2010-09-09 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
WO2010132833A1 (en) 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
EP3756684A1 (en) 2009-05-22 2020-12-30 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
BRPI1014031A2 (pt) * 2009-06-16 2018-02-20 Univ Michigan Regents vacinas de nanoemulsão
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
US20110200683A1 (en) * 2010-02-16 2011-08-18 Piper Medical, Inc Hydrogen peroxide solution producing first aid substance, packaging, and treatment
US20110229516A1 (en) * 2010-03-18 2011-09-22 The Clorox Company Adjuvant phase inversion concentrated nanoemulsion compositions
US20110229512A1 (en) * 2010-03-19 2011-09-22 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating urinary tract infections
CA2794841C (en) 2010-05-20 2021-02-23 Ecolab Usa Inc. Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
US9492525B2 (en) 2011-07-06 2016-11-15 Nanobio Corporation Human respiratory syncytial virus vaccine
US10206996B2 (en) 2011-08-22 2019-02-19 Nanobio Corporation Herpes simplex virus nanoemulsion vaccine
JP6460792B2 (ja) 2011-09-09 2019-01-30 ナノバイオ コーポレーション ナノエマルション呼吸器合胞体ウイルス（ｒｓｖ）サブユニットワクチン
EP2782597B1 (en) 2011-11-23 2022-04-13 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CN102526139A (zh) * 2012-02-23 2012-07-04 华子昂 一种人工阴道液及其制备方法
FR2997304B1 (fr) * 2012-10-26 2017-07-07 Isp Investments Inc Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
CN103830726A (zh) * 2012-11-23 2014-06-04 魏维 抗微生物有机纳米组合物及其制备方法
KR20140141857A (ko) * 2013-05-31 2014-12-11 한국생명공학연구원 패실로마이세스 속 균주를 이용한 생물 농약 제조방법
EP4112076A1 (en) 2014-10-10 2023-01-04 The Regents of The University of Michigan Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
US20180344817A1 (en) 2015-05-01 2018-12-06 Precision Biosciences, Inc. Precise deletion of chromosomal sequences in vivo and treatment of nucleotide repeat expansion disorders using engineered nucleases
US11173197B2 (en) 2015-07-07 2021-11-16 Bluewillow Biologics, Inc. Methods and compositions for nanoemulsion vaccine formulations
US10603363B2 (en) 2015-09-08 2020-03-31 Precision Biosciences, Inc. Treatment of retinitis pigmentosa using engineered meganucleases
CN117070468A (zh) 2015-10-05 2023-11-17 精密生物科学公司 包含经修饰的人T细胞受体α恒定区基因的经遗传修饰的细胞
EP3359660B1 (en) 2015-10-05 2019-12-04 Precision Biosciences, Inc. Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
EP3988655A3 (en) 2015-12-23 2022-08-03 Precision Biosciences, Inc. Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene
WO2017189893A1 (en) 2016-04-27 2017-11-02 University Of Puerto Rico 1,5-disubstituted 1,2,3-triazoles are inhibitors of rac/cdc42 gtpases
DK3452583T3 (da) 2016-05-03 2022-01-10 Prec Biosciences Inc Konstruerede nukleaser, der er nyttige til behandling af hæmofili a
US12076397B2 (en) 2016-05-10 2024-09-03 The Regents Of The University Of Michigan Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
WO2017201390A1 (en) 2016-05-19 2017-11-23 The Regents Of The University Of Michigan Novel adjuvant compositions
JP6897031B2 (ja) * 2016-09-01 2021-06-30 住友ベークライト株式会社 防カビ剤、防カビ樹脂フィルム、防カビ積層フィルム及び防カビ包装体
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物
ES2925644T3 (es) 2016-10-04 2022-10-19 Prec Biosciences Inc Dominios coestimuladores para su uso en células modificadas genéticamente
IL265921B2 (en) 2016-10-14 2024-05-01 Prec Biosciences Inc Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome
WO2018073393A2 (en) 2016-10-19 2018-04-26 Cellectis Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
EP3612205B9 (en) 2017-04-21 2023-10-04 Precision Biosciences, Inc. Engineered meganucleases specific for recognition sequences in the pcsk9 gene
WO2018201144A1 (en) 2017-04-28 2018-11-01 Precision Biosciences, Inc. Methods for reducing dna-induced cytotoxicity and enhancing gene editing in primary cells
EP4029943A1 (en) 2017-05-08 2022-07-20 Precision Biosciences, Inc. Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
CA3068465A1 (en) 2017-06-30 2019-01-03 Precision Biosciences, Inc. Genetically-modified t cells comprising a modified intron in the t cell receptor alpha gene
EP3684436B1 (en) 2017-09-22 2024-11-27 Becton, Dickinson and Company 4% trisodium citrate solution for use as a catheter lock solution
US20200239544A1 (en) 2017-10-03 2020-07-30 Precision Biosciences, Inc. Modified epidermal growth factor receptor peptides for use in genetically-modified cells
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
US20200299658A1 (en) 2017-11-01 2020-09-24 Precision Biosciences, Inc. Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
TW201945388A (zh) 2018-04-12 2019-12-01 美商精密生物科學公司 對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶
CA3095795A1 (en) 2018-04-12 2019-10-17 Precision Biosciences, Inc. Optimized engineered nucleases having specificity for the human t cell receptor alpha constant region gene
US11369578B2 (en) 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
EP3880173A1 (en) 2018-11-15 2021-09-22 Bluewillow Biologics, Inc. Nanoemulsion compositions having enhanced permeability
US20220090047A1 (en) 2018-12-21 2022-03-24 Precision Biosciences, Inc. Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
CN109845757A (zh) * 2019-03-15 2019-06-07 威海市农业科学院 果园用病虫害铲除剂及其制备方法、使用方法
JP7286796B2 (ja) 2019-04-03 2023-06-05 プレシジョン バイオサイエンシズ，インク． マイクロｒｎａ適合ｓｈｒｎａ（ｓｈｒｎａｍｉｒ）を含む遺伝子改変免疫細胞
EP4004216A1 (en) 2019-07-25 2022-06-01 Precision BioSciences, Inc. Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
AU2020333851A1 (en) 2019-08-20 2022-03-31 Precision Biosciences, Inc. Lymphodepletion dosing regimens for cellular immunotherapies
JP7101375B2 (ja) * 2019-10-17 2022-07-15 タマ化学工業株式会社 除菌組成物及びそれを用いる細菌芽胞の除菌方法
WO2021087305A1 (en) 2019-10-30 2021-05-06 Precision Biosciences, Inc. Cd20 chimeric antigen receptors and methods of use for immunotherapy
US12410418B2 (en) 2019-12-06 2025-09-09 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
EP4069285A1 (en) 2019-12-06 2022-10-12 Precision BioSciences, Inc. Methods for cancer immunotherapy, using lymphodepletion regimens and cd19, cd20 or bcma allogeneic car t cells
CN111110631A (zh) * 2020-03-20 2020-05-08 苏国霞 一种高效广谱的抗菌纳米乳及其制备方法
US20230183664A1 (en) 2020-05-11 2023-06-15 Precision Biosciences, Inc. Self-limiting viral vectors encoding nucleases
US12595469B2 (en) 2020-05-12 2026-04-07 Precision Biosciences, Inc. Treatment of retinitis pigmentosa using improved engineered meganucleases
WO2022035793A1 (en) 2020-08-10 2022-02-17 Precision Biosciences, Inc. Antibodies and fragments specific for b-cell maturation antigen and uses thereof
AU2021329403A1 (en) 2020-08-21 2023-05-04 Precision Biosciences, Inc. Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene
JP2022060747A (ja) * 2020-10-05 2022-04-15 サンスター株式会社 抗ウイルス用口腔用組成物
CA3172481A1 (en) 2020-11-12 2022-05-19 Precision Biosciences, Inc. Engineered meganucleases having specificity for recognition sequences in the dystrophin gene
WO2022150616A1 (en) 2021-01-08 2022-07-14 Precision Biosciences, Inc. Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene
WO2022165111A1 (en) 2021-01-28 2022-08-04 Precision Biosciences, Inc. Modulation of tgf beta signaling in genetically-modified eukaryotic cells
EP4326862A1 (en) 2021-04-22 2024-02-28 Precision Biosciences, Inc. Engineered meganucleases that target human mitochondrial genomes
CA3173245A1 (en) 2021-04-22 2022-10-22 James Jefferson Smith Engineered meganucleases that target human mitochondrial genomes
EP4419111A1 (en) 2021-10-19 2024-08-28 Precision Biosciences, Inc. Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
MX2024004840A (es) 2021-10-19 2024-07-09 Prec Biosciences Inc Método de edición de genes para tratar la deficiencia de alfa-1 antitripsina (aat).
WO2023081767A1 (en) 2021-11-05 2023-05-11 Precision Biosciences, Inc. Methods for immunotherapy
WO2024148167A1 (en) 2023-01-05 2024-07-11 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for the human t cell receptor alpha constant region gene
WO2024216116A1 (en) 2023-04-14 2024-10-17 Precision Biosciences, Inc. Muscle-specific expression cassettes
KR20260010765A (ko) 2023-04-14 2026-01-21 프리시젼 바이오사이언시스 인코포레이티드 근육-특이적 발현 카세트
WO2025101946A1 (en) 2023-11-08 2025-05-15 Precision Biosciences, Inc. Polypeptide linkers for use in engineered meganucleases
WO2025233894A1 (en) 2024-05-09 2025-11-13 University Of Miami Engineered meganucleases that target human mitochondrial genomes
WO2026028165A1 (en) 2024-08-01 2026-02-05 Precision Biosciences, Inc. Engineered meganucleases having specificity for recognition sequences in the c9orf72 gene

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT986794B (it) * 1971-04-02 1975-01-30 Lepetit Spa Schiuma detergente ad azione tonificante
US4451267A (en) * 1982-09-29 1984-05-29 The United States Of America As Represented By The Secretary Of Agriculture Microemulsions from vegetable oil and aqueous alcohol with trialkylamine surfactant as alternative fuel for diesel engines
US4599088A (en) * 1984-08-30 1986-07-08 Texaco Inc. Clear stable gasoline-alcohol-water motor fuel composition
JPS63221835A (ja) * 1987-03-09 1988-09-14 Lion Corp 安定な水中油型エマルジヨンの製造方法
JP2506125B2 (ja) * 1987-10-06 1996-06-12 雄二 加藤 殺菌及び柔軟剤組成物
US4895452A (en) 1988-03-03 1990-01-23 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5103497A (en) 1989-11-14 1992-04-07 Hicks John W Flying spot endoscope
US5108660A (en) 1990-01-29 1992-04-28 The Procter & Gamble Company Hard surface liquid detergent compositions containing hydrocarbyl amidoalkylenesulfobetaine
US5709879A (en) 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
US5389369A (en) 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
JPH05124910A (ja) * 1991-10-31 1993-05-21 Takeshi Uchibori 殺菌消毒液及びこれを用いる殺菌消毒材
JPH06279268A (ja) * 1993-01-27 1994-10-04 Takeda Chem Ind Ltd 消毒殺菌剤およびこれを含有するエアゾール組成物
JP3487359B2 (ja) * 1993-09-30 2004-01-19 株式会社資生堂 殺菌洗浄用組成物
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5368837A (en) 1994-04-14 1994-11-29 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
US5549901A (en) 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
DE69527624T2 (de) * 1994-05-20 2003-04-03 Novavax, Inc. Antimikrobielle öl-in-wasser-emulsionen
US5547677A (en) 1994-05-20 1996-08-20 Novavax, Inc. Antimicrobial oil-in-water emulsions
WO1997026855A1 (en) 1996-01-24 1997-07-31 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
US5662957A (en) 1996-05-03 1997-09-02 Novavax, Inc. Oil containing lipid vesicles with marine applications
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5700679A (en) 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
FR2750329B1 (fr) * 1996-06-28 1998-08-14 Oreal Emulsion huile-dans-eau ultrafine gelifiee et stabilisee par un poly(acide 2 -acrylamido 2 -methylpropane sulfonique) reticule et neutralise a au moins 90 %, procede de preparation et applications
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
US6361787B1 (en) 1998-05-27 2002-03-26 The Clorox Company Enhanced antimicrobial composition
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections

Also Published As

Publication number Publication date
HK1055897A1 (en) 2004-01-30
JP2012136533A (ja) 2012-07-19
EP1242095A4 (en) 2005-03-16
CN1433314A (zh) 2003-07-30
US6506803B1 (en) 2003-01-14
EP2364709A1 (en) 2011-09-14
JP5013495B2 (ja) 2012-08-29
ES2425971T3 (es) 2013-10-18
JP2003519184A (ja) 2003-06-17
MXPA02006564A (es) 2004-07-30
EP1242095A1 (en) 2002-09-25
CN1433314B (zh) 2011-08-31
DK1242095T3 (da) 2013-08-12
AU2609901A (en) 2001-07-16
WO2001049296A1 (en) 2001-07-12
EP1242095B1 (en) 2013-05-29
CA2395678A1 (en) 2001-07-12
CA2395678C (en) 2012-06-26
EP2364709B1 (en) 2012-11-28

Similar Documents

Publication Publication Date Title
BR0016796A (pt) Composições antimicrobianas e métodos de uso
MXPA04002781A (es) Emulsiones agua en aceite que comprenden polimeros de vinilo que portan grupos acidos en cadenas laterales, composiciones y metodos.
ATE479419T1 (de) Wässrige dispersion wasserunlöslicher organischer uv-filtersubstanzen
CY1111119T1 (el) Φαρμακευτικα σκευασματα που περιλαμβανουν κολλοειδες διοξειδιο του πυριτιου
CA2528095C (en) Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
MXPA04002779A (es) Emulsiones agua en aceite que comprenden polimeros de vinilo que portan grupos de oxido de etileno en las cadenas laterales, composiciones y metodos.
BR0213877A (pt) Compostos orgânicos
ATE282109T1 (de) Wäschezusatzbeutel
DK1679305T3 (da) 9-substituerede minocyclinforbindelser
BR0113161A (pt) Arilóxi piperidinas não imidazóis
ES2143172T3 (es) Microemulsiones desinfectantes.
BRPI0815828A2 (pt) Formulação de emulsão que impede interação através da interface água-óleo
WO2005009943A3 (en) Substituted tetracycline compounds
BR0014282A (pt) Vacinas
ES2119850T3 (es) Utilizacion de suavizantes acuosos para el tratamiento de textiles.
HRP20080235T3 (hr) Formulacija vakcine koja sadrži emulziju ulje-u-vodi
AR021624A1 (es) Composiciones para el lavado
BR0210828A (pt) Preparações de agentes corantes à base de água para a impressão inkjet
MXPA03004828A (es) Composiciones de poliomeros de dispersion liquida, su preparacion y su uso.
AR017117A1 (es) Una composicion laminar, esferulitica o de fase l2, para su uso en fluidos de perforacion.
BR0013012A (pt) Composição contendo substância ativa, sua produção e seu uso
EA200801250A1 (ru) Эмульсии, содержащие свободное поверхностно-активное вещество в водной фазе, в качестве адъюванта сплит вакцин против гриппа
DE69814943D1 (de) Silizium enthaltende Verbindung und organische elektrolumineszente Vorrichtung, in welcher diese verwendet wird.
EA200400200A1 (ru) Молекулярные метки для систем органических растворителей
AR023447A1 (es) Dispersiones acuosas de productos quimicos agricolas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]